Radioactive Iodine and the Salivary Glands
- 1 March 2003
- journal article
- review article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 13 (3), 265-271
- https://doi.org/10.1089/105072503321582060
Abstract
Radioactive iodine (131I) targets the thyroid gland and has been proven to play an effective role in the treatment of differentiated papillary and follicular cancers. Simultaneously, this radioisotope hones in on the salivary glands where it is concentrated and secreted into the saliva. Dose related damage to the salivary parenchyma results from the 131I irradiation. Salivary gland swelling and pain, usually involving the parotid, can be seen. The symptoms may develop immediately after a therapeutic dose of 131I and/or months later and progress in intensity with time. In conjunction with the radiation sialadenitis, secondary complications reported include xerostomia, taste alterations, infection, increases in caries, facial nerve involvement, stomatitis, candidiasis, and neoplasia. Prevention of the 131I sialadenitis may involve the use of sialogogic agents to hasten the transit time of the radioactive iodine through the salivary glands. However, studies are not available to delineate the efficacy of this approach. Recently, amifostine has been advocated to prevent the effects of irradiation. Treatment of the varied complications that may develop encompass numerous approaches and include gland massage, sialogogic agents, duct probing, antibiotics, mouthwashes, good oral hygiene, and adequate hydration.Keywords
This publication has 28 references indexed in Scilit:
- Mukoepidermoid-Karzinom der Speicheldrüsen nach hochdosierter RadioiodtherapieLaryngo-Rhino-Otologie, 2001
- Tumors after Radiotherapy for Thyroid Cancer; A case-control study within a cohort of thyroid cancer patientsActa Oncologica, 1992
- Klinisches Bild und mögliche Ursachen der Funktionsstörungen der Glandula parotis bei der Radiojodtherapie des differenzierten Schilddrüsenkarzinoms*Laryngo-Rhino-Otologie, 1988
- TWO CASES OF LYMPHOMA OF THE PAROTID GLAND FOLLOWING ABLATIVE RADIOIODINE THERAPY FOR THYROID CARCINOMAClinical Endocrinology, 1982
- Funktionsszintigraphie der Speicheldrüsen nach hochdosierter Radiojodtherapie*RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1976
- Salivary gland scinti‐scanning with technetium 99m pertechnetateThe Laryngoscope, 1969
- CHEWING TOBACCO AND RADIOIODINEThe Lancet, 1967
- IODINE METABOLISM OF SALIVARY GLANDSAnnals of the New York Academy of Sciences, 1960
- Radiation Sialitis following Radioiodine TherapyThe British Journal of Radiology, 1957
- The Role of Radioiodine in the Treatment of Carcinoma of the ThyroidThe British Journal of Radiology, 1956